Exact FDA event identifier

Event 98508

1 recalled-product record grouped only because every row carries this exact official event ID.

Event summary

Timeline bucket: March 02, 2026
Product types: Drug
Classifications: Class II
Statuses: Ongoing
Recalling firm wording: STRIDES PHARMA INC

Dossier provenance

Source snapshots represented here

openFDA Drug Enforcement Report-date coverage June 20, 2012–July 08, 2026 Known gap: openFDA describes 2004-present coverage, but the current export has no report-date records in this interval.

Enforcement coverage uses report dates; product initiation dates can precede those bounds. Device-enrichment coverage uses FDA event_date_initiated.

How coverage and grouping work

Device root-cause evidence is not applicable to this event. No grouped product has the official product type device; this is not an unavailable-enrichment finding.

Complete imported group

Every recalled product in this event

1 official enforcement rows

Product dates, classifications, firms, and source wording remain attached to their individual rows. Opening this dossier never hides products that did not match a prior timeline filter.

drug · product 1 of 1

Children's Ibuprofen Oral Suspension, USP, 100 mg per 5mL, 4 FL OZ (120 mL) bottle, Manufactured for: Taro Pharmaceuticals U.S.A., Inc., Hawthorne, NY 10532, Made in India, NDC 51672-5321-8.

D-0390-2026

Recall number: D-0390-2026
Initiated: March 02, 2026
Classification: Class II
Status: Ongoing
Recalling firm: STRIDES PHARMA INC
Quantity: 89592 bottles

App-derived interpretation

Foreign material or chemical contamination reason.foreign_material_chemical_contamination · v1.0.0

foreign substance

These labels are deterministic app interpretations, not FDA categories.

Inspect official wording and provenance

Reason for recall

Presence of foreign substance: the firm received complaints for a gel-like mass and black particles in the product.

Code information

Lot: 7261973A, 7261974A, Exp 01/31/2027

Distribution pattern

U.S.A. Nationwide